Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOPHER M KRAMER

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1528137148
CMS profile
1061444
Location
CHARLOTTESVILLE, VA

General Payments · PY2018–2024

$79,802.20

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,616.73

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Eli Lilly and Company $7,651.00 9
BioMarin Pharmaceutical Inc. $1,800.00 2
Siemens Medical Solutions USA, Inc. $165.73 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $36.58 2
PY2019 $408.85 3
PY2020 $735.08 2
PY2021 $24,637.50 13
PY2022 $28,115.38 19
PY2023 $16,252.08 12
PY2024 $9,616.73 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
BioMarin Pharmaceutical Inc. $1,575.00 01/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127062908 CMS
BioMarin Pharmaceutical Inc. $225.00 01/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127062910 CMS
Eli Lilly and Company $1,400.00 04/15/2024 Consulting Fee Undisputed 01/23/2026 1136098126 CMS
Eli Lilly and Company $700.00 07/18/2024 Consulting Fee Undisputed 01/23/2026 1136110898 CMS
Eli Lilly and Company $301.00 08/21/2024 Consulting Fee Undisputed 01/23/2026 1136122678 CMS
Eli Lilly and Company $875.00 09/23/2024 Consulting Fee Undisputed 01/23/2026 1136104940 CMS
Eli Lilly and Company $700.00 09/23/2024 Consulting Fee Undisputed 01/23/2026 1136125199 CMS
Eli Lilly and Company $350.00 10/04/2024 Consulting Fee Undisputed 01/23/2026 1136110900 CMS
Eli Lilly and Company $700.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 1136125201 CMS
Eli Lilly and Company $875.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1136102312 CMS
Eli Lilly and Company $1,750.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1136101496 CMS
Siemens Medical Solutions USA, Inc. $25.64 07/02/2024 Food and Beverage Undisputed 01/23/2026 1093696970 CMS
Siemens Medical Solutions USA, Inc. $90.90 07/10/2024 Food and Beverage Undisputed 01/23/2026 1093696972 CMS
Siemens Medical Solutions USA, Inc. $49.19 07/22/2024 Food and Beverage Undisputed 01/23/2026 1093696968 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.